Lou Gehrig's Disease (ALS): Progress and Promise in Stem Cell Research

CIRM has funded the ALS Disease Team led by scientists at who aim to bring a human embryonic stem cell based ALS therapy to clinical trials within four years. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, is a progressive motor neuron disorder. Most people with ALS die within 3 to 5 years from the onset of symptoms. For more information visit CIRM's ALS disease fact sheet and The ALS Association website.



Disease Programs

Learn about how stem cell research could generate the therapies for many chronic diseases and injuries

See disease fact sheets

CIRM Stem Cell Blog